Therapeutic potential of angiotensin II receptor antagonists

被引:12
|
作者
White, M [2 ]
Racine, N
Ducharme, A
de Champlain, J
机构
[1] Univ Montreal, Dept Physiol, Montreal, PQ H1T 1C8, Canada
[2] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
关键词
angiotensin II; angiotensin receptor blockade; cardiovascular function;
D O I
10.1517/13543784.10.9.1687
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The circulating renin angiotensin system plays an important role in cardiovascular homeostasis. More importantly, the local tissue renin angiotensin plays a pivotal role in cell growth and remodelling of cardiomyocytes and on the peripheral arterial vasculature. in addition, the renin angiotensin system is related to apoptosis, control of baroreflex and autonomic responses, vascular remodelling and regulation of coagulation, inflammation and oxidation. The cardioprotective and vascular protective effects of the angiotensin receptive blockade appears to be related to selective blockade of the Type I angiotensin II receptors. However, there is now growing evidence showing that some of the effects of angiotensin II receptor blockers (ARBs) are related to the activation of the kinin pathways. This paper will review some of the recent mechanisms related to the cardiovascular effects of angiotensin and more specifically of ARBs. This paper will present the novel data on the role of ARB in the development of atherosclerosis, vascular remodelling, coagulation balance and autonomic regulation. Finally, the role of ARBs, used alone or in combination with ACE inhibitor in patients with heart failure, will be discussed.
引用
收藏
页码:1687 / 1701
页数:15
相关论文
共 50 条
  • [21] Metabolic syndrome and angiotensin II receptor antagonists
    Mamyrbayeva, K. M.
    Mychka, V. B.
    Sergienko, V. B.
    Chazova, L. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (02): : 42 - +
  • [22] Antagonists of the AT1 receptor for angiotensin II
    Kawecka-Jaszcz, Kalina
    Czarnecka, Danuta
    Wojciechowska, Wiktoria
    ARTERIAL HYPERTENSION, 2006, 10 : A1 - A15
  • [23] Angiotensin II receptor antagonists for heart failure
    Struthers, AD
    HEART, 1998, 80 (01) : 5 - 6
  • [24] Angiotensin II receptor antagonists: The prototype losartan
    Schaefer, KL
    Porter, JA
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) : 625 - 636
  • [25] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    TIMMERMANS, PBMWM
    WONG, PC
    CHIU, AT
    HERBLIN, WF
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (02) : 55 - 62
  • [26] Angiotensin II receptor antagonists in arterial hypertension
    Hernández-Hernández, R
    Velasco, M
    Armas-Hernández, MJ
    Armas-Padilla, MC
    JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) : S69 - S72
  • [27] Safety and efficacy of angiotensin II receptor antagonists
    Neutel, JM
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (2A): : 13K - 17K
  • [28] The comparative pharmacology of angiotensin II receptor antagonists
    Burnier, M
    Maillard, M
    BLOOD PRESSURE, 2001, 10 : 6 - 11
  • [29] Angiotensin-II receptor antagonists - Comment
    Scheler, F
    INTERNIST, 1996, 37 (05): : 538 - 538
  • [30] Angiotensin II-receptor antagonists: An overview
    Dina, R
    Jafari, M
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (13) : 1231 - 1241